Fri, Dec 26, 2014, 12:27 AM EST - U.S. Markets open in 9 hrs 3 mins


% | $
Quotes you view appear here for quick access.

CR Bard Inc. Message Board

  • kattie Dec 7, 2005 8:25 PM Flag

    Takeover Candidate

    Listen to the Bard
    Medical device company C.R. Bard (BCR:NYSE - commentary - research - Cramer's Take) is also likely a takeover target, said Cramer. But, Cramer would be interested Bard even if it weren't a takeover target because it has great fundamentals and it's one of the few medical device companies not to receive a subpoena from the Department of Justice in its investigation of industry sales practices.

    A takeover, which Cramer believes would happen at about $100 a share, would be the icing on the cake, he said. Bard closed Wednesday's regular session at $67.07.

    Cramer said that there are too many medical device companies and that the industry is ripe for consolidation. Because of the strong dollar, which attracts foreign investment, and a low tax rate environment for stocks, "anyone who wants to do a merger deal wants to do it before these two very positive conditions evaporate," he said.

    Cramer believes that the loser of the fight between Johnson & Johnson (JNJ:NYSE - commentary - research - Cramer's Take) and Boston Scientific (BSX:NYSE - commentary - research - Cramer's Take) for Guidant (GDT:NYSE - commentary - research - Cramer's Take) would be the likely buyer.

169.10-0.44(-0.26%)Dec 24 1:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Gilead Sciences Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST